1.
Chetan Dev, Rana Muhammad Naveed, Nur Qistina Binti Mohammed Haniff, Lavinya Vasudevan, Haider Hasnain, Jerin Xavier Polackal, et al. LONG-TERM CARDIOVASCULAR OUTCOMES AND SAFETY PROFILE OF PCSK9 INHIBITORS IN HIGH-RISK POPULATIONS FOR SECONDARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A COMPREHENSIVE META-ANALYSIS OF MORTALITY, MAJOR ADVERSE CARDIAC EVENTS, AND METABOLIC IMPACT. IJHR [Internet]. 2024 Nov. 30 [cited 2026 Jun. 2];2(2 (Health & Allied):381-8. Available from: https://insightsjhr.com/index.php/home/article/view/199